FSU biologist pursuing new HIV treatments through psychostimulant drugs

Working under the support of a $1.8 million grant from the National Institutes of Health, Florida State biologist Jonathan Dennis is studying a unique ability shared between a promising class of HIV treatments known as histone deacetylase inhibitors (HDIs) and psychostimulant drugs such as cocaine.